Nuzenio

Therapeutics Price Target

Therapeutics Price Target news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.stsimplywall.st · Mon, 10 Aug 2026 11:05:52 GMTThe Voyager Therapeutics, Inc. (NASDAQ:VYGR) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.stsimplywall.st · Mon, 10 Aug 2026 10:42:47 GMTTruist Adjusts Price Target on Protagonist Therapeutics to $170 From $145, Maintains Buy Rating - marketscreener.commarketscreener.com · Mon, 10 Aug 2026 10:15:38 GMTDimensional Fund Advisors LP Has $12.87 Million Stock Position in Cullinan Therapeutics, Inc. $CGEM - MarketBeatMarketBeat · Sun, 09 Aug 2026 07:33:23 GMTBridgeBio Oncology Therapeutics, Inc. Stock 12‑Month Price Target Cut to $24.89, Implies 167% Upside - TradingViewTradingView · Sat, 08 Aug 2026 20:20:06 GMTZevra Therapeutics, Inc. (ZVRA) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Sat, 08 Aug 2026 09:07:44 GMTAkebia Therapeutics Price Target Announced at $1.00/Share by Leerink Partners - MoomooMoomoo · Sat, 08 Aug 2026 00:30:00 GMTHalozyme Therapeutics, Inc. Stock 12‑Month Price Target Raised to $99.56, Implies 16% Upside - TradingViewTradingView · Fri, 07 Aug 2026 21:20:19 GMT

Timeline

Mon, 10 Aug 2026 11:05:52 GMTIntellia Therapeutics, Inc. (NASDAQ:NTLA) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
Mon, 10 Aug 2026 10:42:47 GMTThe Voyager Therapeutics, Inc. (NASDAQ:VYGR) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
Mon, 10 Aug 2026 10:15:38 GMTTruist Adjusts Price Target on Protagonist Therapeutics to $170 From $145, Maintains Buy Rating - marketscreener.com
Sun, 09 Aug 2026 07:33:23 GMTDimensional Fund Advisors LP Has $12.87 Million Stock Position in Cullinan Therapeutics, Inc. $CGEM - MarketBeat
Sat, 08 Aug 2026 20:20:06 GMTBridgeBio Oncology Therapeutics, Inc. Stock 12‑Month Price Target Cut to $24.89, Implies 167% Upside - TradingView
Sat, 08 Aug 2026 09:07:44 GMTZevra Therapeutics, Inc. (ZVRA) Stock Price, News, Quote & History - Yahoo! Finance Canada

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Therapeutics Price Target.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.